مسؤولية منتج الدواء عن الفعل الضار في النظام القانوني الاتحادي

Abstract EN

Even a simple error in the manufacturing of a medicine could have disastrous consequences; and the risk is even greater when harm or risk takes place over span of time and symptoms were not expected at the time of medicine production.

In the absence of a legislation regulating medicine manufacturers' liability for their harmful products in UAE, the study throws spotlight on the general rules of liability for harmful acts, demonstrating the extent of protection such rules provide to consumer.

Study also determines liability of medicine manufacturers and sellers in the light of the hefty profits such industry generates.

The study covers medicine manufacturers' scope of liability for the harmful act, turning spotlight on liability for personal acts and liability arising from areas requiring specific attention.

It also covers provisions of liability for harmful act including scope of medicine manufacture's liability claim and cases of exemption from liability for harmful act.

Study sums up with that articles of pharmacy profession and pharmaceutical institutions failed to regulate this obligation, and that the federal legal system lacks a unified law concerning the regulation of provisions related to human health and safety in terms of food, treatment, cosmetics, etc.